INBP
INTEGRATED BIOPHARMA INC
Key Financials
Net Income
$808000
↑ 621.4%
Operating Income
$2.0M
↑ 704.8%
EPS (Diluted)
$0.03
↑ Infinity%
Total Liabilities
$4.6M
↓ 34.2%
Shareholders' Equity
$20.3M
↑ 5.6%
Gross Profit
$5.6M
↑ 43.2%
Total Assets
$24.9M
↓ 5.0%
Revenue
$43.7M
↓ 6.9%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| 8-K | 5/8/2026 | View on SEC |
| 10-Q | 5/8/2026 | View on SEC |
| SCHEDULE 13D/A | 4/17/2026 | View on SEC |
| SCHEDULE 13D | 4/17/2026 | View on SEC |
| 4/A | 4/17/2026 | View on SEC |
| 4 | 4/17/2026 | View on SEC |
| 4 | 4/17/2026 | View on SEC |
| 4 | 4/17/2026 | View on SEC |
| 8-K | 4/15/2026 | View on SEC |
| 4 | 3/26/2026 | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | INBP |
| Company Name | INTEGRATED BIOPHARMA INC |
| CIK | 1016504 |
| Sector | Pharmaceutical Preparations |
| Industry | Non-accelerated filer Smaller reporting company |
| Exchange | OTC |
| SIC Code | 2834 |
| SIC Description | Pharmaceutical Preparations |
| Entity Type | operating |
| Fiscal Year End | 0630 |
| State of Incorporation | DE |
| Phone | 9739260816 |